Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


AMA Grants MycoDART CPT Code For Its Life-Saving Test


 

MycoDART, Inc., developer of proprietary DNA tests, announced its second patented assay has been granted a CPT code from the American Medical Association. MycoDART-PCR for Aspergillus joins MycoDART-PCR for Candida as one of very few diagnostic devices without FDA clearance to be recognized by the AMA.

MycoDART's rapid diagnostic tests allow for the early detection of invasive fungal infections in immune-compromised patients, such as those undergoing transplants, as well as those with cancer and AIDS. Both tests have been clinically validated and are available for physicians to order from the company's affiliate, RealTime Laboratories, Inc., a Texas based clinical lab accredited by CLIA and the College of American Pathology. MycoDART has also teamed up with several prestigious university hospitals to conduct dual clinical studies.

University of Augusta, UC Davis, University of Pennsylvania, Henry Ford Health, and the University of Texas at Houston are currently at work on a study to collect samples from patients with suspected exposure to Candida. The study will compare results of MycoDART-PCR with those of blood cultures, the current gold standard. The purpose of the studies is to demonstrate efficacy in the clinical environment. Baylor Health System will lead the second study, which will employ the Aspergillus assay.

Dr. Jose Vazquez is an infectious disease specialist at the University of Augusta and is the principal investigator on Candida study. According to Dr. Vazquez, "A reliable diagnostic to quickly and accurately identify these deadly infections is long overdue. Relying on blood culture, which is a hundred year old technology that is often wrong, puts the patients at further risk."

MycoDART-PCR uses a unique process to detect very small amounts of DNA in human samples. Unlike blood cultures, which can take days to get results and are only 50% accurate, MycoDART's accuracy is as high as 95%, and results are available within hours of receiving the specimen. Early and rapid diagnosis of invasive fungal infections is key to saving lives and driving down the cost of treatment.

Immune-compromised patients face mortality within hours of being infected if not treated appropriately. Without an accurate diagnosis, doctors must treat with costly and toxic broad-spectrum antifungals. This treatment leads to lengthier hospital stays and more complications. Targeting the right organism with the most effective drug provides the best possible outcome for the patient, the hospital and the third-party payer.

 
Share:

Related Articles:


Recent Articles

TMA Issues Statement on Medicaid Block Grant Proposal

The largest professional organization for doctors in Tennessee has submitted its public comments regarding the proposal to convert federal funding for TennCare to a block grant.

Read More

Blackburn, McSally & Others Urge Improved Breast Cancer Screening for Servicewomen, Veterans

A bipartisan group of senators is urging the Pentagon to revamp breast cancer screening options for Tricare beneficiaries.

Read More

Gauging Reactions

Pros and cons to Gov. Lee's block grant proposal expressed by Tennessee's healthcare leaders.

Read More

Governor Rolls Out TennCare Modified Block Grant Proposal

Tennessee Governor Bill Lee looks to do something no state has done before in crafting a modified block grant to give the state more flexibility, share of savings in managing Medicaid.

Read More

Leadership Health Care Expands Programming to Boston

LHC took a slight detour from their annual D.C. Delegation and headed to Boston instead to study a healthcare ecosystem that differs from Nashville's own.

Read More

More than Just a Number

VUMC's Harvey Murff, MD, stays busy training providers, dispelling myths about geriatric care.

Read More

The Challenges of Identifying, Treating Behavioral Health Issues in the Geriatric Popu-lation

Comorbid conditions, often including some form of dementia, increases the challenge of pinpointing and treating behavioral health and substance abuse issues in older populations.

Read More

Senior Living Solutions Evolve to Meet Resident Needs

As residents' needs and acuity levels have risen, senior living solutions have had to evolve to meet new health and wellness challenges.

Read More

COA of Middle Tennessee Releases Eldercare Report

Caring for an elderly relative while working takes a toll on both employees and employers. COA is working to improve community supports.

Read More

Improving Senior Care across the Continuum

naviHealth ensuring better outcomes for better quality of life.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: